Physician profile
Sean Marvil
NPI 1891924668
$8,579.33
in general payments reported to CMS, 2019-2025
14 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,639 · 2020: $478 · 2021: $2,540 · 2022: $639 · 2023: $827 · 2024: $949 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759 · Travel and Lodging: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.52 |
| Travel and Lodging | $525.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,487.51 | 2019-2022 | |
| Medacta USA, INC. | $1,319.67 | 2019-2025 | Reverse Shoulder |
| Smith+Nephew, INC. | $869.53 | 2020-2025 | Journey II, Real Intelligence, Visionaire |
| Stryker Corporation | $845.64 | 2019-2025 | Inspace, Aequalis Ascend Flex, Aequalis Perform Reversed |
| Fx Shoulder Solutions, INC | $669.24 | 2019-2022 | |
| Gemini Mountain Medical, LLC | $460.13 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $331.28 | 2019-2021 | |
| Alliance Medical | $201.83 | 2025 | |
| Depuy Synthes Sales INC. | $149.82 | 2019-2020 | |
| Breg, INC | $134.96 | 2023 | Breg Vpulse, Plasmaflow, Polarcarewave |
| Pacira Pharmaceuticals Incorporated | $39.83 | 2023 | Zilretta, Iovera |
| Djo, LLC | $35.78 | 2019 | |
| Pacira Therapeutics, INC. | $17.22 | 2021 | |
| Vericel Corporation | $16.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Marvil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.